Drug Shortage Report for UROCIT-K
Report ID | 151911 |
Drug Identification Number | 02353997 |
Brand name | UROCIT-K |
Common or Proper name | Potassium Citrate Extended Release Tablets |
Company Name | MISSION PHARMACAL COMPANY |
Market Status | MARKETED |
Active Ingredient(s) | POTASSIUM CITRATE |
Strength(s) | 1080MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 100-ct |
ATC code | A12BA |
ATC description | POTASSIUM |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2021-12-24 |
Actual start date | 2021-12-22 |
Estimated end date | 2022-02-15 |
Actual end date | 2022-02-22 |
Shortage status | Resolved |
Updated date | 2022-02-23 |
Company comments | Delay from label supplier. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 10999 IH 10 WEST SAN ANTONIO, TEXAS UNITED STATES 78230-1355 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2022-02-23 | English | Compare |
v8 | 2022-02-22 | French | Compare |
v7 | 2022-02-22 | English | Compare |
v6 | 2022-01-31 | French | Compare |
v5 | 2022-01-31 | English | Compare |
v4 | 2022-01-03 | French | Compare |
v3 | 2022-01-03 | English | Compare |
v2 | 2021-12-28 | French | Compare |
v1 | 2021-12-28 | English | Compare |
Showing 1 to 9 of 9